{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T18:31:40Z","timestamp":1648751500993},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00117-021-00929-w","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T13:02:50Z","timestamp":1635858170000},"page":"1129-1138","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gastroenteropankreatische neuroendokrine Tumoren"],"prefix":"10.1007","volume":"61","author":[{"given":"Nada","family":"Rayes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timm","family":"Denecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"key":"929_CR1","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao\u00a0JC, Hassan\u00a0M, Phan\u00a0A, Dagohoy\u00a0C et\u00a0al (2008) One hundred years after \u201ecarcinoid\u201c: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J\u00a0Clin Oncol 26:3063\u20133072","journal-title":"J Clin Oncol"},{"key":"929_CR2","first-page":"13","volume-title":"WHO classification of tumours of the digestive tract","author":"G Rindi","year":"2010","unstructured":"Rindi\u00a0G, Arnold\u00a0R, Bosman\u00a0FT et\u00a0al (2010) Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman\u00a0FT, Hruban\u00a0RH, Theise\u00a0ND (Hrsg) WHO classification of tumours of the digestive tract. IARC, Lyon, S\u00a013\u201314"},{"key":"929_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/cncr.23549","volume":"113","author":"UF Pape","year":"2008","unstructured":"Pape\u00a0UF, Jann\u00a0H, M\u00fcller-Norhorn\u00a0J et al (2008) Prognostic relevance of a\u00a0novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumours. Cancer 113:256\u2013265","journal-title":"Cancer"},{"key":"929_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00428-007-0452-1","volume":"451","author":"G Rindi","year":"2007","unstructured":"Rindi\u00a0G, Kl\u00f6ppel\u00a0G, Coulevard\u00a0A, Komminoth\u00a0O et\u00a0al (2007) TNM staging of midgut and hindgut neuroendocrine tumors: a\u00a0consensus proposal including a\u00a0grading system. Virchows Arch 451:757\u2013762","journal-title":"Virchows Arch"},{"issue":"Suppl 7","key":"929_CR5","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/cncr.23648","volume":"113","author":"RT Jensen","year":"2008","unstructured":"Jensen\u00a0RT et\u00a0al (2008) Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 113(Suppl 7):1807\u20131843","journal-title":"Cancer"},{"key":"929_CR6","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1055\/a-0661-6099","volume":"56","author":"S Maasberg","year":"2018","unstructured":"Maasberg\u00a0S et al (2018) Neuroendokrine Neoplasien im deutschen NET-Register. Z\u00a0Gastroenterol 56:1237\u20131246","journal-title":"Z Gastroenterol"},{"issue":"4","key":"929_CR7","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1677\/ERC-10-0152","volume":"17","author":"MB Niederle","year":"2010","unstructured":"Niederle\u00a0MB, Hackl\u00a0M, Kaserer\u00a0K, Niederle\u00a0B (2010) Gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 17(4):909\u2013918","journal-title":"Endocr Relat Cancer"},{"issue":"06","key":"929_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1055\/a-0604-2924","volume":"56","author":"A Rinke","year":"2018","unstructured":"Rinke\u00a0A, Wiedenmann\u00a0B, Auernhammer\u00a0C et al (2018) S2k-Leitlinie Neuroendokrine Tumore. Z\u00a0Gastroenterol 56(06):583\u2013681. https:\/\/doi.org\/10.1055\/a-0604-2924","journal-title":"Z Gastroenterol"},{"key":"929_CR9","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1245\/s10434-010-1006-3","volume":"17","author":"IM Modlin","year":"2010","unstructured":"Modlin\u00a0IM, Gustafsson\u00a0BI, Moss\u00a0SF, Pavel\u00a0M, Tsolakis\u00a0AV, Kidd\u00a0M (2010) Chromogranin A\u2014biological function and clinical utility in neuroendocrine tumor disease. Ann Surg Oncol 17:2427\u20132443","journal-title":"Ann Surg Oncol"},{"key":"929_CR10","series-title":"AWMF-Reg. 021-27","volume-title":"S2k-Leitlinie Neuroendokrine Tumore","author":"A Rinke","year":"2018","unstructured":"Rinke\u00a0A, Wiedenmann\u00a0B, Auernhammer\u00a0C et al (2018) S2k-Leitlinie Neuroendokrine Tumore. AWMF-Reg. 021-27"},{"key":"929_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000472254","volume":"105","author":"K Oberg","year":"2017","unstructured":"Oberg\u00a0K et\u00a0al (2017) ENETS consensus guidelines for standard of care in neuroendocrine tumours: biochemical markers. Neuroendocrinology 105:201\u2013211","journal-title":"Neuroendocrinology"},{"key":"929_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1200\/JCO.2015.64.0987","volume":"34","author":"SM Sadowski","year":"2015","unstructured":"Sadowski\u00a0SM et al (2015) Prospective study of 68ga-DOTATATE positron emission tomography\/computed tomography for detecting gastro-entero-pancreatic neuroendocrine tumors and unknown primary sites. J\u00a0Clin Oncol 34:588\u2013596","journal-title":"J Clin Oncol"},{"key":"929_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000457956","volume":"105","author":"A Perren","year":"2017","unstructured":"Perren\u00a0A et\u00a0al (2017) ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pathology: diagnosis and prognostic stratification. Neuroendocrinology 105:196\u2013200","journal-title":"Neuroendocrinology"},{"key":"929_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000443171","volume":"103","author":"M Falconi","year":"2016","unstructured":"Falconi\u00a0M, Eriksson\u00a0B, Kaltsas\u00a0G et al (2016) ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumours and non-functional pancreatic neuroendocrine tumours. Neuroendocrinology 103:153\u2013171","journal-title":"Neuroendocrinology"},{"key":"929_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000464292","volume":"105","author":"S Partelli","year":"2017","unstructured":"Partelli\u00a0S et\u00a0al (2017) ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology 105:255\u2013265","journal-title":"Neuroendocrinology"},{"key":"929_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000443168","volume":"103","author":"G Delle Fave","year":"2016","unstructured":"Delle Fave\u00a0G et\u00a0al (2016) ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms. Neuroendocrinology 103:119\u2013124","journal-title":"Neuroendocrinology"},{"key":"929_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.suc.2009.06.018","volume":"89","author":"EH Morrow","year":"2009","unstructured":"Morrow\u00a0EH, Norton\u00a0JA (2009) Surgical management of Zollinger-Ellison syndrome; state of the art. Surg Clin North Am 89:1091\u20131103","journal-title":"Surg Clin North Am"},{"key":"929_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000371807","volume":"101","author":"MK Kim","year":"2015","unstructured":"Kim\u00a0MK et\u00a0al (2015) Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors. Neuroendocrinology 101:58\u201365","journal-title":"Neuroendocrinology"},{"key":"929_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1245\/s10434-015-4654-5","volume":"23","author":"CH Yuan","year":"2016","unstructured":"Yuan\u00a0CH et al (2016) Meta-analysis of liver resection versus nonsurgical treatments for pancreatic neuroendocrine tumors with liver metastases. Ann Surg Oncol 23:244\u2013249","journal-title":"Ann Surg Oncol"},{"key":"929_CR20","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1200\/JCO.2010.33.7873","volume":"29","author":"A Imhof","year":"2011","unstructured":"Imhof\u00a0A, Brunner\u00a0P, Marincek\u00a0N et al (2011) Response, survival and long-term toxicity after therapy with the radiolabeled somatostatin analogue 90Y-DOTA-TOC in metastasized neuroendocrine cancers. J\u00a0Clin Oncol 29:2416\u20132423","journal-title":"J Clin Oncol"}],"container-title":["Der Radiologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-021-00929-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-021-00929-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-021-00929-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:02:55Z","timestamp":1639180975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-021-00929-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["929"],"URL":"https:\/\/doi.org\/10.1007\/s00117-021-00929-w","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,2]]},"assertion":[{"value":"2 November 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>N.\u00a0Rayes<\/b>: A. Finanzielle Interessen: N.\u00a0Rayes gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B. Nichtfinanzielle Interessen: Leiterin, Endokrine Chirurgie, Lehrbeauftragte, Klinik und Poliklinik f\u00fcr Viszeral\u2011, Transplantations\u2011, Thorax- und Gef\u00e4\u00dfchirurgie, Universit\u00e4tsklinikum Leipzig A\u00f6R. <b>T.\u00a0Denecke<\/b>: A. Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: b.e. imaging, Guerbet, Siemens.\u00a0\u2013 Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: Canon, Siemens, Bayer, Bracco, AstraZeneca, MSD, Roche, Novartis, IPSEN, Parexel, Merck.\u00a0\u2013 B. Nichtfinanzielle Interessen: Klinikumsdirektor, Klinik und Poliklinik f\u00fcr Diagnostische und Interventionelle Radiologie, Universit\u00e4tsklinikum Leipzig | Mitgliedschaften: Berliner R\u00f6ntgengesellschaft \u2013 R\u00f6ntgenvereinigung zu Berlin und Brandenburg (BRG-RBB; 1.\u00a0Vorsitzender), S\u00e4chsische Radiologische Gesellschaft (SRG), Deutsche R\u00f6ntgengesellschaft (DRG), Deutsche Gesellschaft f\u00fcr Nuklearmedizin (DGN), European Society of Radiology (ESR), Deutsche Gesellschaft f\u00fcr Interventionelle Radiologie und minimal-invasive Therapie (DeGIR), Cardiovascular and Interventional Radiological Society of Europe (CIRSE), European Neuroendocrine Tumor Society (ENETS; Advisory Board), <i>BMC Medical Imaging<\/i> (Editor), <i>Acta Radiologica<\/i> (Editor).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}